Yahoo Finance

Octave MSDA Test Gains NY State Certification, Expanding Access Nationwide

The Only Clinically Validated Multiple Sclerosis Multi-Analyte Test Proven to Deliver Clinically Meaningful Insights Is Now Available In All 50 States MENLO PARK, Calif., April 29, 2025--(BUSINESS ...
Yahoo Finance

Octave Bioscience Awarded Valhalla Foundation Grant to Accelerate Development of the First MS Disease Progression Test

MENLO PARK, Calif., October 06, 2025--(BUSINESS WIRE)--Octave Bioscience, Inc., a commercial-stage precision care company pioneering biomarker-driven solutions for multiple sclerosis (MS) and other ...
Seeking Alpha

Octave Bioscience Forms Strategic Collaboration with Quest Diagnostics to Expand Patient Access to the Octave® Multiple Sclerosis Disease Activity (MSDA) Test Across the ...

Collaboration enables patients to access the Octave MSDA test at Quest’s approximately 7,000 patient access sites across the U.S. and establishes a pathway to introduce additional tests from Octave’s ...
Yahoo Finance

Octave Bioscience’s MSDA Test Proven to Provide Clinically Actionable Insights That Drive Meaningful Clinical Decisions in MS Care

MENLO PARK, Calif., April 16, 2025--(BUSINESS WIRE)--Octave Bioscience, Inc., a leading precision care company that delivers a new standard for managing multiple sclerosis (MS) and other ...
Investing

Quest Diagnostics to offer Octave’s MS blood test nationwide

MENLO PARK, Calif. - Octave Bioscience announced Monday a strategic collaboration with Quest Diagnostics (NYSE:DGX) to make its Multiple Sclerosis Disease Activity (MSDA) Test available through ...